SLC3A2 and neoplasm: In our investigation, bioinformatics analyses have indicated that elevated SLC3A2 expression not only has been associated with adverse clinicopathological features but also as a potential regulator of the tumor immune microenvironment, suggesting its involvement in modulating immune cellular dynamics, notably the M2 macrophage infiltration.